CNSX:BAMM

28896 Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume20,889 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

28896 (CNSX:BAMM) Vs. RIV, WLLW, LABS, KHRN, DN, and META

Should you be buying BAMM stock or one of its competitors? Companies in the industry of "drug manufacturers—specialty & generic" are considered alternatives and competitors to 28896, including RIV Capital (RIV), Willow Biosciences Inc. (WLLW.TO) (WLLW), MediPharm Labs (LABS), Khiron Life Sciences (KHRN), Delta 9 Cannabis (DN), and Meta Growth (META).

28896 (CNSX:BAMM) and RIV Capital (TSE:RIV) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Analyst Ratings

This is a breakdown of current recommendations and price targets for 28896 and RIV Capital, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
288960000N/A
RIV Capital01002.00

RIV Capital has a consensus target price of C$4.00, indicating a potential upside of 96.08%.

Valuation & Earnings

This table compares 28896 and RIV Capital's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
28896N/AN/AN/AN/AN/A
RIV CapitalC$15.44 million18.49C$-106,223,568.00C($0.76)-2.69

28896 has higher earnings, but lower revenue than RIV Capital.

Profitability

This table compares 28896 and RIV Capital's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
28896N/AN/AN/A
RIV CapitalN/AN/AN/A

Summary

RIV Capital beats 28896 on 1 of the 1 factors compared between the two stocks.

28896 (CNSX:BAMM) and Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk.

Profitability

This table compares 28896 and Willow Biosciences Inc. (WLLW.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
28896N/AN/AN/A
Willow Biosciences Inc. (WLLW.TO)N/AN/AN/A

Earnings & Valuation

This table compares 28896 and Willow Biosciences Inc. (WLLW.TO)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
28896N/AN/AN/AN/AN/A
Willow Biosciences Inc. (WLLW.TO)C$10,000.0015,778.30C$-51,032,952.00C($0.41)-3.09

28896 has higher earnings, but lower revenue than Willow Biosciences Inc. (WLLW.TO).

Analyst Ratings

This is a breakdown of recent ratings for 28896 and Willow Biosciences Inc. (WLLW.TO), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
288960000N/A
Willow Biosciences Inc. (WLLW.TO)0000N/A

Willow Biosciences Inc. (WLLW.TO) has a consensus price target of C$2.25, suggesting a potential upside of 75.78%.

Summary

Willow Biosciences Inc. (WLLW.TO) beats 28896 on 1 of the 1 factors compared between the two stocks.

MediPharm Labs (TSE:LABS) and 28896 (CNSX:BAMM) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares MediPharm Labs and 28896's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$36.01 million3.33$-123,815,040.00C($0.48)-0.97
28896N/AN/AN/AN/AN/A

28896 has lower revenue, but higher earnings than MediPharm Labs.

Profitability

This table compares MediPharm Labs and 28896's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MediPharm LabsN/AN/AN/A
28896N/AN/AN/A

Analyst Ratings

This is a summary of current ratings for MediPharm Labs and 28896, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MediPharm Labs02023.00
288960000N/A

MediPharm Labs presently has a consensus target price of C$1.53, suggesting a potential upside of 229.03%.

Summary

MediPharm Labs beats 28896 on 2 of the 2 factors compared between the two stocks.

Khiron Life Sciences (CVE:KHRN) and 28896 (CNSX:BAMM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings and dividends.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Khiron Life Sciences and 28896, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Khiron Life Sciences0000N/A
288960000N/A

Khiron Life Sciences presently has a consensus target price of C$1.20, indicating a potential upside of 135.29%.

Profitability

This table compares Khiron Life Sciences and 28896's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Khiron Life SciencesN/AN/AN/A
28896N/AN/AN/A

Earnings & Valuation

This table compares Khiron Life Sciences and 28896's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Khiron Life SciencesC$8.01 million9.56$-39,493,921.00C($0.26)-1.94
28896N/AN/AN/AN/AN/A

28896 has lower revenue, but higher earnings than Khiron Life Sciences.

Summary

Khiron Life Sciences beats 28896 on 1 of the 1 factors compared between the two stocks.

28896 (CNSX:BAMM) and Delta 9 Cannabis (TSE:DN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for 28896 and Delta 9 Cannabis, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
288960000N/A
Delta 9 Cannabis00014.00

Delta 9 Cannabis has a consensus target price of C$1.10, indicating a potential upside of 89.66%.

Earnings & Valuation

This table compares 28896 and Delta 9 Cannabis' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
28896N/AN/AN/AN/AN/A
Delta 9 CannabisC$52.05 million1.14C$-7,339,680.00C($0.07)-8.06

28896 has higher earnings, but lower revenue than Delta 9 Cannabis.

Profitability

This table compares 28896 and Delta 9 Cannabis' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
28896N/AN/AN/A
Delta 9 CannabisN/AN/AN/A

Summary

Delta 9 Cannabis beats 28896 on 2 of the 2 factors compared between the two stocks.

Meta Growth (CVE:META) and 28896 (CNSX:BAMM) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Earnings and Valuation

This table compares Meta Growth and 28896's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthC$60.96 million0.54$-50,412,840.00C($0.21)-0.66
28896N/AN/AN/AN/AN/A

28896 has lower revenue, but higher earnings than Meta Growth.

Analyst Recommendations

This is a summary of current ratings and price targets for Meta Growth and 28896, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth0000N/A
288960000N/A

Profitability

This table compares Meta Growth and 28896's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
28896N/AN/AN/A

Summary

Meta Growth beats 28896 on 1 of the 1 factors compared between the two stocks.


28896 Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
RIV
RIV Capital
0.8$2.04flatC$285.50 millionC$15.44 million-2.69
WLLW
Willow Biosciences Inc. (WLLW.TO)
1.1$1.28flatC$157.78 millionC$10,000.00-3.09Gap Down
LABS
MediPharm Labs
1.4$0.47flatC$119.95 millionC$36.01 million-0.97
KHRN
Khiron Life Sciences
0.9$0.51flatC$67.34 millionC$8.01 million-1.94Gap Down
DN
Delta 9 Cannabis
1.4$0.58flatC$59.18 millionC$52.05 million-8.06
META
Meta Growth
0.8$0.14flatC$36.69 millionC$60.96 million-0.66Gap Up
NRTH
48North Cannabis
0.7$0.14flatC$36.44 millionC$17.36 million-0.53
CSI
(CSI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ATT
Abattis Bioceuticals
0.5N/AN/AC$0.00N/A0.00Gap Down
AGRA
Agraflora Organics International
1.4N/AN/A$0.00N/A0.00High Trading Volume
GRIN
Grindrod Shipping
1.7N/AN/A$0.00N/A0.00High Trading Volume
IMCC
IM Cannabis
0.0N/AN/A$0.00N/A0.00High Trading Volume
PULL
Mind Cure Health
1.7N/AN/A$0.00N/A0.00High Trading Volume
SPR
Spirit AeroSystems
0.5N/AN/A$0.00N/A0.00High Trading Volume
BUZZ
VanEck Vectors Social Sentiment ETF
1.0N/AN/A$0.00N/A0.00High Trading Volume
VIDA
Vidaroo
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.